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Abstract
The interaction between chemokine receptor type 4 (CXCR4) and its ligand, stromal cell-derived factor (SDF)-1, plays an
important role in stem cell mobilization and migration in ischemic tissues. MicroRNAs (miRs) are key regulators of stem cell
function and are involved in regulation of stem cell survival and differentiation to adopt different cell lineages. In this study,
we show that ischemia inhibits the expression of miR-150 in BM-derived mononuclear cells (MNC) and activates its target
Cxcr4 gene. Our results show that miR-150/CXCR4 cascade enhances MNC mobilization and migration. By using mouse
acute myocardial infarction (MI) model, we found that MNCs in peripheral blood (PB) were increased significantly at day 5
after AMI as compared to control group and the number of CXCR4 positive MNCs both in bone marrow (BM) and PB was
also markedly increased after MI. Analysis by microarray-based miRNA profiling and real-time PCR revealed that the
expression of miR-150 which targets Cxcr4 gene as predicted was significantly downregulated in BM-MNCs after MI.
Abrogation of miR-150 markedly increased CXCR4 protein expression suggesting its target gene. To show that miR-150
regulates MNC mobilization, knockdown of miR-150 in BM-MNCs by specific antisense inhibitor resulted in their higher
migration ability in vitro as compared to scramble-transfected MNCs. Furthermore, in vivo BM transplantation of MNCs
lacking miR-150 expression by lentiviral vector into the irradiated wild type mice resulted in the increased number of MNCs
in PB after AMI as compared to control. In conclusion, this study demonstrates that ischemia mobilizes BM stem cells via
miR-150/CXCR4 dependent mechanism and miR-150 may be a novel therapeutic target for stem cell migration to the
ischemic tissue for neovascularization and repair.
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Introduction
Ischemic heart disease is a leading cause of death worldwide. As
a result of an insufficient blood supply of the heart muscle by
coronary occlusion, loss of viable cardiomyocytes and the
reduction of cardiac output can be induced during AMI phase.
BM-derived mononuclear cells including endothelial progenitor
cells (EPCs) play an important role in the maintenance of vascular
integrity [1,2]. Since MNCs/EPCs are able to differentiate into
mature endothelial cells and promote repair of damaged
endothelium, they are attractive target for the repair of ischemic
tissue [3–5]. MNC/EPC number and function are closely
associated with coronary endothelial function, and reduced levels
of circulating MNCs/EPCs have been shown to be independent
predictors of atherosclerotic disease progression [6]. Therefore,
sufficient MNC/EPC numbers, as well as the capacity to
differentiate into mature endothelial cells are considered to be
essential for myocardial functional recovery and infarct size
reduction.
Interaction between stromal cell-derived factor-1a (SDF-1a,o r
CXCL12a) and its receptor CXC chemokine receptor 4 (CXCR4,
or fusin/CD184) plays a key role in mobilization of vascular stem/
progenitor cells [7]. As one of the strategies to rescue cardiac
dysfunctions after AMI, the modification of CXCR4 expression in
BM-derived stem cells has been investigated by using various BM-
derived stem cells [8]. For instance, hypoxic preconditioning of
cardiac stem/progenitor cells (cardiosphere-derived, Lin
2 c-kit
+
progenitor cells) upregulates CXCR4 expression and increases the
recruitment of these cells into the ischemic myocardium, thereby
reducing the infarct size and improving the cardiac function after
MI [9]. In addition, intravenous delivery of mesenchymal stem
cells (MSCs) overexpressing CXCR4 improves cardiac function
and remodeling after MI, suggesting CXCR4 as an important
therapeutic target for the treatment of cardiovascular diseases
[10].
MicroRNAs (miRs) play an important role in the posttranscrip-
tional regulation of target mRNA in a range of biological
processes, including maintenance of stemness and modulation of
mobilization, proliferation and differentiation. miRNAs are short
(19–23 nucleotides), noncoding small regulatory RNAs that are
loaded into the RNA-induced silencing complex, recognize the 39-
untranslated region (UTR) of target genes, and thereby regulate
their expression by translational repression or mRNA degradation.
[11,12] Donahue and colleagues have previously profiled miR
expression in response to Plerixafor (AMD3100, hematopoietic
mobilizing agent) and granulocyte colony-stimulating factor (G-
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positive cell populations based on miR expression signatures,
suggesting each miRs may regulate different group of BM cell
mobilization [13–15]. However, the functional role of specific
miRs and their targets for cell mobilization remains to be
investigated.
Here we report CXCR4 expression as a target of miR-150
which is downregulated in BM-derived MNCs in response to
AMI, leading to MNC mobilization and migration in PB.
Materials and Methods
Experimental Mouse model of AMI
C57BL/6 mice (female, 12 weeks old) were anesthetized by
intrapertoneal injection of ketamine/xylazine (100 mg/kg and
20 mg/kg body weight, respectively). After endotracheal intuba-
tion and mechanical ventilation using Harvard Appratus Mini-
Vent (Type 845), a left intercostal thoracotomy was performed to
open the chest. Left anterior descending coronary artery was
permanently ligated with 6-0 silk (Echicon) and the chest was
closed. For post-mortem studies, we sacrificed animals using
overdose of sodium pentobarbital. All experimental procedures
were performed in accordance with the standard human care
guidelines of the ‘‘Guide for the Care and Use of Laboratory
Animals’’ and were approved by the Institutional Animal Care
and Use Committee of University of Cincinnati (Protocol ID: 06-
03-13-03), which conforms to National Institutes of Health
guidelines.
Isolation of MNCs
One ml of peripheral blood was harvested from control and
AMI mice by aspiration from heart. Total BM cells were obtained
by flushing the cavity of femurs, tibias, and ilium and bone
fragments were filtered through a 40 mm filter. MNCs were
isolated by density-gradient centrifugation using 1.083 g/ml
Histopaque 1083 solution (Sigma-Aldrich). Briefly, Histopaque
1083 was added to centrifuge tube and whole blood was carefully
loaded onto surface of the histopaque. Then, histopaque with
whole blood was centrifuged at 400 g for exactly 30 minutes at
room temperature. After discarding upper layer, the opaque
inferface containing the MNC layer was transferred into a 15 ml
tube and washed with PBS twice by centrifugation. After the final
wash, MNCs were used for further study.
miRs profiling with microarray
Total RNA samples obtained from PB- and BM-MNCs of
control and AMI mice were sent to LC Sciences (Houston, TX) for
miRs microarray profiling. Data were analyzed by LC Sciences
with in-house developed computer programs. Intensity values were
transformed into log2 scale, and fold changes were given in log2
scale. A t-test was performed between non-infarcted MNCs and
infarcted MNCs from hearts, and statistical significance was
considered at p,0.01.
miRs isolation and detection
Total RNA, including miRs, was extracted by using mirVana
miR isolation kit (Ambion) in accordance with the manufacturer’s
instructions. miR-150 was detected by using RT
2 miRNA First
Strand Kit (SA biosciences) and specific miR-150 primers from
QIAGEN were used for quantitative reverse transcription (qRT)
PCR and real time PCR. Relative expression was calculated using
the comparative Ct method (2
2[D][D]Ct).
Transfection of MNCs with miR inhibitor
To knockdown miR-150 in MNCs, transfection was performed
with anti-miR-150 (miRCURY LNA microRNA inhibitor,
Exiqon) by electroporation system according to the instruction of
manufacture (Electroporator II, Invitrogen). Briefly, 10610
6 BM-
MNCs were resuspended in 400 ml of DMEM and transferred into
electroporation cuvette. For miR inhibitor electroporation,
100 nM of anti-miR-150 was added and the loaded cuvettes were
placed on ice. Voltage on the Electroporator II was set at 660 V
and an infinite internal resistance value was used. A blank cuvette
containing PBS were discharged at least twice before electropo-
rating cells. MNCs were electroporated two times and then
transferred to culture dish. The electroporated cells were
incubated at 37uCi n5 %C O 2 and examined 48 hr after
electroporation using an appropriate assay.
Migration assay
A total of 1610
6 BM-MNCs suspension in 250 ml serum-free
EBM was placed in the upper chamber of Transwell Boyden
chamber (Coster, 8 mm pore size, Sigma-Aldrich). Then the
chamber was placed in 24 well culture dish containing 500 ml
endothelial basal medium supplemented with 10% fetal bovine
serum, singlequats and 100 ng/ml SDF-1 (Peprotech inc). After
24 hr of incubation at 37uC, the lower side of the filter was washed
with PBS and fixed with 4% paraformaldehyde. Cells migrating to
the lower chamber were stained with 0.1% crystal violet solution.
Migration activity was evaluated as the mean number of migrated
cells in three random microscopic fields (4006) per chamber.
FACS analysis
PB- and BM-derived MNCs were resuspended in PBS
containing 1% bovine serum albumin and were incubated for
30 min in the dark at 4uC with phycoerythrin (PE) -conjugated
monoclonal CXCR4 antibody (R&D). Cells were washed three
times by centrifuging with 1 ml of PBS for 5 min at 400 g before
analysis.
Western blot analysis
MNCs were lysed in lysis buffer, pH 7.4 [(in mM) 50 HEPES, 5
EDTA, 50 NaCl], 1% Triton X-100, protease inhibitors [(10 mg/
ml aprotinin, 1 mM phenylmethylsulfonyl fluoride, 10 mg/ml
leupeptin) and phosphatase inhibitors [(in mM) 50 sodium
fluoride, 1 sodium orthovanadate, 10 sodium pyrophosphate].
The protein samples (40 mg) were electrophoresed using SDS-
polyacrylamide gel and electro-immunoblotted as described. The
specific antibody used for the detection of CXCR4 was purchased
from ProSci Inc.
miRs target gene prediction
Computational analyses to predict potential binding between 39
UTR of target genes and miRNA was carried out with the
following databases: microRNA.org (version 2010), TargetScan-
Mouse (version 5.1) and MirBase (version 4). Only common
targets were considered for experimental analysis.
Lentivirus-mediated miR-150 inhibition in MNCs
miR-150 overexpressing vector and scramble plasmid were
obtained from GeneCopoeia. Lentivirus overexpressing miR-150
was generated by using Lenti-Pac HIV Expression Packaging Kit
(GeneCopoeia). Briefly, 2.5 ml of lentiviral miR-150 inhibitor
expression plasmid/control plasmid, 5.0 ml of EndoFectin Lenti
and EndoFectin Lenti reagent were added in Opti-MEM I, and
formed the DNA-EndoFectine complex. Twenty min after
miR-150 Targets Cxcr4 to Regulate MNC Mobilization
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Fectine complex was added in the dish which 293Ta cells were
plated in DMEM with 10% FBS and incubated in 5% CO2 at
37uC overnight. The culture medium was replaced with fresh
DMEM with 5% FBS and 1/500 volume of the TiterBoost
reagent to the culture medium and continued to be incubated.
The virus pseudovirus-containing culture medium was collected
48 hr post transfection and concentrated after filtration. For the
transduction of BM-MNCs with lentivirus, 10610
6 of MNCs was
plated and 20 ml of virus suspension was added. The cells were
placed for 2 hr at 4uC and then transferred to the plate in a 5%
CO2 at 37uC for 48 h.
Figure 1. AMI increases the numbers of BM-MNCs and CXCR4 positive MNCs. (A) MNCs were isolated at 1, 3 and 5 days after left anterior
descending artery ligation (LAD) and analyzed for molecular characterization. (B) The number of PB-MNCs decreased at one day after LAD ligation
and increased gradually up to 5 days (n$10 in each groups). (C) The percentage of CXCR4 positive cells in MNCs increased in both PB and BM after
LAD ligation as compared to control. (n=8 in control group and n=6 in AMI group). (D) Densitometric analysis of CXCR4 positive MNCs counted after
LAD ligation.
doi:10.1371/journal.pone.0023114.g001
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Recipient C57BL/6 mice were exposed to a single sublethal
dose of 5.5 Gy total-body c-irradiation. BM-MNCs from donor
mice were infected with Lentivirus overexpressing miR-150 as
described above. Lentivirus transfected-MNCs were counted, and
5610
6 cells were injected into recipient mice via retro-orbital
venous sinus at 6–8 hr after irradiation. Injection into the retro-
orbital sinus was easier to perform but more invasive than using
the tail vein [16,17]. The mice were subjected to AMI and
harvested MNCs from BM and PB at 5 days after AMI were
analyzed as described above.
Statistical analysis
All values were expressed as means 6 SE. Comparison between
two mean values was made by an unpaired Student two-tailed t-
test. Statistical significance was accepted at p,0.05.
Results
AMI increases mobilization of BM-derived MNCs and
CXCR4 positive cells into PB
To examine whether AMI induces MNC mobilization from BM
into PB, we assessed the number of MNCs in PB from mice at 1, 3
and 5 days after AMI and control mice as shown in Fig. 1A. The
numbers of MNCs in PB were significantly decreased at day 1
after AMI (38.6% decrease) and markedly increased at day 3
(47.0% increase) and day 5 (110.7% increase) after AMI
(Figure 1B). Furthermore, the percentage of CXCR4 positive
MNCs isolated from both PB and BM of AMI mice was
significantly increased (2.2 and 2.6 fold, respectively) as compared
to those of non-infarcted mice (Figure 1C and D), indicating AMI
induces mobilization of MNCs as well as CXCR4
+ cells into blood
circulation.
miRs expression profiling in BM-derived MNCs from AMI
mice
To examine the potential participation of miRs in mobilization
of MNCs, we performed miR profiling in BM-derived MNCs by
using miRs microarray. As shown in Figure 2A and B, specific sets
of miRs expression decreases more than 2 folds in BM-MNCs
from AMI mice at 3 days as compared to control mice. These
include miR-1937a (23.6 fold), miR-494 (23.39 fold), miR-29c
(23.19 fold), miR-150 (22.95 fold), miR-486 (22.37 fold), miR-
30c (22.35 fold) and miR-30b (22.14 fold). Interestingly, miR-
29c, miR-150, and miR-494 expression was further decreased
more than 4 fold at 5 days (27.28, 24.75, and 24.27,
respectively), which led us to further study the role of these
miRNAs in MNC mobilization.
miR-150 regulates MNC migration by targeting Cxcr4
Since miR microarray analysis revealed that miR-29c, miR-98/
let-7 family, miR-150, miR-195 and miR-494 expression was
significantly downregulated in BM-derived MNCs, we extensively
examined databases for predicted targets of these miRNAs
involved in MNC mobilization. Computational target prediction
analysis indicated that Cxcr4 is one of the consensus putative
targets of miR-150 relevant to stem cell mobilization (Figure 3A).
To verify microarray profiling results, we performed real time
PCR and confirmed that miR-150 expression was markedly
reduced in BM-derived MNCs from AMI mice (Figure 3B). As
shown in Figure 3C, knockdown of miR-150 by anti-miR-150
markedly reduced CXCR4 protein expression in MNCs, indicat-
ing CXCR4 is a putative target of miR-150 in MNCs. To
investigate the role of miR-150 in migration of MNCs, we
performed in vitro cell migration assay by using Boyden Chamber
transwell system. MNCs isolated from BM of AMI mice exhibited
the higher number of migrated cells in response to SDF-1a as
compared to control MNCs (Figure 3D, upper). Interestingly,
knockdown of miR-150 by transfection with anti-miR-150
significantly increased the number of migrated MNCs when
compared to scramble transfection, suggesting miR-150 is
critically involved in MNC migration (Figure 3D, bottom).
Knockdown of miR-150 enhances mobilization of MNCs
in vivo
To further examine the involvement of miR-150 in stem cell
mobilization in vivo, we performed mouse BM transplantation
experiments by using irradiated mice and lentiviral miR-150
inhibitor. Lentivirus containing mCherry (red, reporter) was
generated by co-transfection of 293Ta cells with Lentiviral vectors
and miR-150 inhibitor or scramble (Figure 4A). We produced
Lentivirus containing anti-miR-150 and miR-scramble and
transduced to MNCs isolated from healthy mice. Lentivirus
transduction efficiency was confirmed by red signal of mCherry
under microscope. Figure 4B showed approximately .90% of
MNCs expressed mCherry at 2 days of Lentivirus infection. In
addition, knockdown of miR-150 in MNCs by lentiviral vector
significantly increased CXCR4 expression (Figure 4C). Interest-
ingly, we found that in vivo transplantation of MNCs lacking miR-
150 expression (
anti-miR-150MNCs) into the irradiated wild type
mice resulted in increased number of MNCs in PB released from
BM as compared to that of MNCs transducing scramble
(
ScMNCs), indicating that miR-150 plays a critical role in MNC
mobilization in BM through Cxcr4 regulation (Figure 4D).
Discussion
It has been reported that transplantation of BM-MNCs in
patients with ischemic heart failure reduces major adverse
cardiovascular events after MI and improved cardiac function
[18,19]. Several experimental studies suggest that most likely,
multiple distinct cell populations of the BM-MNC are capable of
contributing to neovascularization and differentiation into cardiac
myocytes. MNCs systematically mobilized from BM can home to
the sites of ischemic tissues such as infarcted myocardium,
ischemic hindlimb, and the mechanism of MNCs homing to
ischemic tissues has been extensively investigated. miRs are
critically involved in many biological processes in health and
disease including cardiovascular diseases. Although biological
relevance of miRs in many stem cell functions is reported, the
involvement of miRs in stem cell mobilization and migration is
unknown.
In this study, we reported here for the first time that the
expression of miR-150 was downregulated in BM MNCs in
response to myocardial ischemia with simultaneous induction of
CXCR4 protein expression. These molecular events led to
Figure 2. Microarray-based miRs expression profiling in BM-MNCs. (A) Gene tree represented on left and heat map on right of 15
experiments, respectively (n=5). The color of the top bar shows the degree of expression (red; upregulated genes, green; downregulated genes). (B)
The list of miRs whose expression was altered in BM-MNCs in response to LAD ligation.
doi:10.1371/journal.pone.0023114.g002
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UTR as predicted by computational analysis. (B) miR-150 expression was decreased in BM-MNCs after AMI as validated by real-time PCR. (C) CXCR4
protein expression in MNCs significantly increased by transfection with miR-150 inhibitor. (D) BM-MNCs isolated from mice with LAD ligation
enhanced migration capacity of BM-MNCs in response to SDF-1a as evaluated by transwell migration system. Transfection of wild type MNCs with
anti-miR-150 also increased the number of migrating cells.
doi:10.1371/journal.pone.0023114.g003
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microarray-based miR profiling data indicated that miR-29c,
miR-150, and miR-494 expression in BM-MNCs was significantly
decreased by 4 fold at 5 days after AMI and the major objective of
this study was to determine Cxcr4 as a putative target gene of miR-
150. The interaction of SDF-1a/CXCR4 plays a crucial role in
stem cell mobilization. SDF-1a expression is upregulated by
ischemia resulting in the recruitment and homing of hematopoietic
stem/progenitor cells expressing CXCR4 receptor to ischemic
sites [20]. Indeed, intramuscular injection of the chemoattractant
chemokine SDF-1a has recently been shown to increase the
number of incorporated EPCs and to improve neovascularization
in vivo [21]. CXCR4 is a G protein-coupled 7-transmembrane
receptor and plays crucial role in embryonic development as well
as in maintaining the stem cell niche. Our data showed the
numbers of PB-MNCs as well as CXCR4 positive MNCs were
Figure 4. Lentivirus-mediated knockdown of miR-150 augments CXCR4 expression and mobilization of MNCs. (A) Structures of Lenti-
miR-150 inhibitor and Lenti-Sc which contains mCherry reporter gene (red signal), (B) Titeration and transduction efficiency of lentivirus-mediated
miR-150 inhibition in MNCs was evaluated by mCherry signal under microsope. (C) Lentivirus-mediated knockdown of miR-150 elevated CXCR4
protein expression in MNCs. (D) Number of BM-MNCs mobilized to PB was markedly increased in peripheral circulation of BN transplantation of mice
which received MNCs lacking miR-150.
doi:10.1371/journal.pone.0023114.g004
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BM-MNC mobilization by targeting Cxcr4.. Knocking down miR-
150 by transfection with its inhibitor in MNCs exhibited the
higher response to SDF-1a in migration capacity as compared
with scramble-transfected MNCs. Furthermore, lentivirus-medi-
ated knockdown of miR-150 significantly increased CXCR4
expression in MNCs and transplantation of these cells into BM
of wild type mice dramatically increased MNC mobilization from
BM to PB, indicating that miR-150 is critically associated with
stem cell mobilization by regulating Cxcr4.
miR-150 is abundantly expressed in monocytes [22] which is
altered under various conditions including the immune response
and tumorigenesis [23,24]. Therefore, miR-150 is being studied
for its participation in addressing different aspects of cellular
functions with special focus on its role in mobilization of
monocytes. In this regard, c-Myb, a transcription factor related
to endothelial cell migration and B cell differentiation, is being
tipped as a potential target gene of miR-150 [22,25]. Microvesicle-
based exogenous miR-150 delivery to human microvascular
endothelial cells resulted in downregulation of c-MYB expression
and enhanced their migration ability in vitro [25]. Although these
data support our findings to imply miR-150 in cell mobilization,
the discrepancy between the two studies may be attributed to; 1)
different cell types (endothelial cell vs stem cell), 2) cell maturity
(mature vs progenitor cell), 3) exogenous vs endogenous expression
of miR-150, 4) disease type (atherosclerosis vs myocardial
ischemia), all of which might have led to the different results
between these studies. Another research group has identified a
molecular cascade (PLZF transcription factor/miR-146a/
CXCR4) controlling normal megakaryopoiesis which involved
enhanced expression of PLZF and inhibition of miR-146a
transcription [26]. They demonstrated downregulation of miR-
146a elevated the translation of the target CXCR4 mRNA. In this
regulatory loop, miR-146a acted as an effector of PLZF and
mediated its control activity on Cxcr4 translation. Taken together,
these studies indicated the functional significance of miR-150 in
immune system and disease control and, warrant further
investigations to elucidate the functional role of miR-150 in
angiomyogenesis mediated by mobilized MNCs.
In conclusion, our results demonstrated that miR-150 down-
regulation by AMI enhanced CXCR4 expression, leading to
enhanced BM-MNCs mobilization and migration. Thus, miR-150
may be a novel therapeutic target for stimulating BM cell
mobilization to ischemic tissue for participation in the repair
process.
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